To determine the types of alterations in gene structure that are induced by the carcinogen 2-(N-acetoxy-Nacetyl)aminofluorene, we used this compound to generate mutations at the dihydrofolate reductase (DHFR) locus (DHFR) in Chinese hamster ovary cells. Twenty-nine independent enzyme-deficient mutants were isolated.
dent enzyme-deficient mutants were isolated. A profile of the 26-kilobase (kb)-long gene was obtained by Southern blot analysis of the mutant and parental DNAs digested with BstEH/Kpn I. Hybridization to a mixed probe of 10 DHFR genomic and cDNA fragments revealed 12 bands that scan 34 kb. Twenty-one DHFR-clones (72%) contained small mutations (changes <100 base pairs in size). Large or small deletions involving various parts of the gene occurred in eight of the mutants (28%). A large deletion (>35 kb) with 5' and 3' breakpoints mapping to approximately the same location was noted in four mutants. One mutant has undergone a deletion of 550-900 bp that eliminated the first coding exon. Concomitantly, a chromosomal event (either translocation, insertion, or inversion) has separated the 5' flank from the body of the gene. In another mutant, four deletions have occurred at the DHFR 5' end and internally. Restriction fragment length polymorphism analysis of the mutant DNAs with exon-specific probes localized three mutations. One mutant has lost a Taq I (TCGA) site, and another has lost a Sac I (GAGCTC) site. In a third, a GC-)TA transversion has created a BstEl (GGTNACC) site. Finally, we used HPLC to determine the ratio ofacetylated (12%) to deacetylated (88%) 2-aminofluorene adducts formed in the parental cells. A correlation between the mutational specificities and the conformational changes induced by the two types of DNA adducts is discussed.
Exposure of animals to carcinogens results in a series of phenotypic changes in emerging cell populations leading eventually to malignant neoplasia (for review, see ref. 1) . Some of the events responsible for these changes are presumed to involve mutation. Oncogenes isolated from human and animal tumors are capable of inducing malignant transformation upon transfection into cultured cells. Alterations in either the expression or the function of particular oncogenes are implicated in the development of neoplasia. Tumor cells can display a variety ofdifferent types ofmutations in cellular oncogenes. Examples are point mutation (2) , translocation (3), amplification (4) , and insertion (5) .
Information learned about the activation of cellular oncogenes emphasizes the importance of studying chemical carcinogens as mutagens. That carcinogens are mutagenic has been well established in bacteria (6) . Several quantitative assays have been developed to evaluate the mutagenic potential of carcinogens in animal cells (7) (8) (9) . However, less is known about the spectrum of mutations inducible by chemical carcinogens. Molecular biological approaches for characterizing the physical nature of induced genetic changes is possible in cultured mammalian cells for any selectable locus that has been cloned and mapped.
Some studies using DNA probes for Southern (10) blot analysis of carcinogen-mutagenized animal cells have been reported. For instance, analysis of benzo[a]pyrene (11) and 3-methylcholanthrene (12) diol epoxide-induced hypoxanthine phosphoribosyltransferase-deficient (HPRT-) hamster cells showed either no structural alterations (11) or large deletions (12) . It was acknowledged, though, that the deletion mutants (3 out of 22) might be spontaneous in origin rather than induced (12) . In another study, ethyl methanesulfonate was used to generate adenine phosphoribosyltransferasedeficient (APRT-) Chinese hamster cell lines, starting with an APRT' hemizygote (13) . Both induced and spontaneous APRT-alleles were compared. This chemical created single base-pair (bp) changes or other small alterations (<50 bp). To date, no gross structural rearrangements in selectable genes have been characterized at the DNA level after exposure of mammalian cells to a carcinogen.
We are interested in learning the types of gene alterations inducible by chemical carcinogens and the DNA sequence changes engendered in point mutants. We have used a model mammalian gene encoding dihydrofolate reductase (DHFR) to characterize mutations induced in cultured Chinese hamster ovary (CHO) cells by the carcinogen 2-(N-acetoxy-Nacetyl)aminofluorene (AAAF). AAAF reacts predominantly at the C-8 position of deoxyguanosine residues, yielding two types of adducts, acetylated {2-[N-(deoxyguanosin-8-yl)-Nacetyl]aminofluorene (dG-AAF)} and deacetylated [2-(deoxyguanosin-8-yl)aminofluorene (dG-AF)]. These adducts are known to affect DNA conformation differently (14) (15) (16) (17) . Both types of adducts were formed in the DNA of treated CHO cells. DHFR-mutants are readily selectable in a line of CHO cells that is hemizygous for this locus (18) , and probes for the entire region containing the 26-kilobase (kb)-long gene are available (19 (20) to select DHFR-clones. Individual colonies were isolated, and the cells were tested for glycine, thymidine, and hypoxanthine auxotrophy. Only one mutant per dish was analyzed further. Alternatively, mutants were selected in the fluorescence-activated cell sorter as described (21) . Clones displaying the appropriate phenotype were assayed for failure to bind [3H]methotrexate (22) . The subsequent two mutagenesis experiments were performed similarly except that 16 or 20 individual cultures were grown from small inocula and treated with AAAF. In the third experiment, the cells were exposed to AAAF in suspension rather than as monolayers. Characterization of Mutant DNA. Preparation of genomic, plasmid, and fragment DNAs and methods for subcloning, restriction digestion, gel electrophoresis, Southern blot analysis, and nick-translation have been described (19) . For the initial screening of mutant DNA by Southern blotting, a mixed probe of 10 fragments (the "polyprobe") derived from DHFR recombinant plasmids (19) was prepared ( Fig. 1) . Components of the mixed probe were as follows: A, pMH8 3.4-kb Bgl II fragment; B, pB6-14 1.7-kb BamHI-Sac I; C, pB6-14 1.6-kb EcoRI; D, pB61H1 1.8-kb HindIII; E, pB61H3 0.9-kb HindIII; F, pB6-7 3.2-kb BamHI-HindIII; G, pB6-7 2.1-kb HindIII; H, pDCH14 1.1-and 0.28-kb Pst I; and I, pB13-6 0.7-kb BamHI. Exon-specific probes used in the RFLP analysis were pMB5 0.55-kb Sac II (exon I), pMB5 0.7-kb Sac II-BstEII (exon II), pEll-15 1.45-kb Ava I-EcoRI (exon III), pB6-14 1.0-kb EcoRI-BamHI (exon IV), pDCH6 0.23-kb Sac I-Kpn I (a cDNA clone containing exons IV and V, bp 262-489 in ref. 23 ; the Kpn I site is a cloning site), and pDCH14 1.1-and 0.28-kb Pst I (exon VI). Since cDNA for the protein-coding portion of the DHFR gene has been cloned and sequenced (23) , cleavage sites in the exons are known. The parental and mutant DNAs were digested with the following enzymes for analysis of restriction fragment length polymorphism (RFLP): Taq I (exons I and III); BstNI (exons I, III, V, and VI); Hae III (exons I, III, and V); Sca I, EcoRI, and Xmn I (exon II); Hph I, Mbo II, and Msp I (exon III); Sac I (exons III and IV); Ava II and Kpn I (exon VI). To obtain a probe for the 5' flank of the DHFR gene, we cloned a 1.5-kb HindIII fragment located 10.4 kb upstream of exon I from the cosmid clone cH2 (24) . The plasmid, designated pHH15, is devoid of repeated sequences. A 1.5-kb Sma I-EcoRI fragment (5' portion) and a 0.85-kb HindIII-Sma I fragment (3' portion) were purified from the 7.3-kb Sma I insert on another cH2 subclone, designated pH2Sm7. The 3' Sma I site is located 468 bp upstream of the initiation codon (25) (29) . Our initial approach for characterizing the mutants was to digest genomic DNA with Kpn I and BstEII and analyze the digests by Southern blotting and hybridization to the nick-translated mixed probe (polyprobe). These enzymes create 12 resolvable bands scanning 34 kb of the locus. An example of the mixed probe screening is depicted in Fig. 1 . If the DNA banding pattern of a mutant was identical to that of the parental cell line UA21, it was designated as carrying a small lesion, possibly a point mutation, deletion, or insertion. Sequence changes of 100 bp or less are below the resolution limit of this technique. Table 1 lists the 29 AAAF-induced DHFR-clones analyzed; of these, 21 were categorized as having small mutations.
Mutagenesis by AAAF also generated structurally different types of lesions in the DHFR locus. Three mutants with gross alterations in the gene are shown in Fig. 1 . A complete deletion (>34 kb) has occurred in DF17. Another mutant, DF20, has lost the 4.4-kb Kpn I fragment and a new band at 2.3 kb is evident. The 3.4-kb band containing the 5' end of the gene is missing in DF27. The latter two mutants were further characterized (Figs. 2 and 3, respectively) . It is apparent that exon V has been eliminated from DF20, -because cDNA sequences for this portion of the coding region do not hybridize (Fig. 2, probe A) . The Kpn I site, located 229 bp upstream from the 5' end of exon V (29) , is retained in the mutant. Thus, one end of the deletion is near the 3' boundary of intron IV. Probe C of Fig. 2 shows that the deletion terminates within the 5' end of intron V.
The screening of DF27 indicated a rearrangement at the 5' end of the DHFR gene. More detailed examination (Fig. 3) showed that a deletion had occurred, since an exon I-specific probe (probe C) failed to hybridize to DF27 DNA. Rehybridization of the filter with three other probes from this region revealed that the deletion was relatively small. The maximum size of the deletion is about 900 bp, since a Bgi II site at bp -720 and a Pst I site at bp +206 are still present in DF27 DNA. The minimum size is =550 bp, the size of probe C. The sequences 5' and 3' of the deletion are not colinear as in the case of DF20. Cutting with enzymes (Kpn I, Bgi II, HindIII, HincII, EcoRI, BstEII) that surround the deletion site yielded a pattern that cannot be reconciled with the wild-type map (Fig. 3 and data not shown) . Hence, a disruption of the DHFR gene has occurred in DF27 concom- itant with and close to the deletion. A map of the DHFR 5' end of UA21 is shown in Fig. 3 and is compared with that of DF27. The region 5' of the gene in the mutant is depicted as being attached to a different segment of chromosome. The remainder of the gene, which is anomalously joined to another region, is drawn below. The mutant may have undergone a translocation moving either the 5' flank or the body of the gene to a new location. Alternatively, we cannot rule out a large insertion or inversion.
In the first set of mutants isolated (Table 1) , four (DF21, DF11, DF13, and DF91) appeared to carry a similar large deletion. Analysis of three of them is shown in Fig. 4 . suggests that the deletion may have the same 5' and 3' endpoints in these four mutants.
Another type of structurally rearranged mutant, DF10, was isolated from the same mutagenesis experiment as the four deletion mutants. The analysis of DF10 is summarized in Fig.  5 . The results can be interpreted by correlating the results shown at the bottom of Fig. 5 with the map shown at the bottom of Fig. 1 . To differentiate the bands that are apparent on the screening autoradiograph, the filter was serially hybridized with each individual component of the mixed probe, as well as with the upstream probe from pHH15. Four deletions have occurred within the DHFR locus of this mutant. One deletion extends from the 5' flank past exon III (>21 kb). Three additional deletions apparently have occurred within the remainder of the gene.
We attempted to localize small mutations by RFLP analysis. Designations of these mutants isolated from the three experiments are as follows: DF11-1, DF31, DF51, DF41, DF12X1, and DF81 (experiment 1); DF14, DF16, DF18, DF19, DF26, and DF29 (experiment 2); and DF30, DF31-1, DF32, DF35, DF40, DF42, DF43, DF44, and DF47 (experiment 3). DNA of these mutants was digested with 12 enzymes that each cut at least once in the DHFR exons (see Fig. 1 Regarding the mutational specificity of AAAF, four mutants were isolated in experiment 1 that appear to carry a similar large deletion, one that leaves only about 20% of the DHFR gene remaining at the 3' end (Fig. 4) . The mutagenesis protocol in that experiment rules out the possibility that these identical mutants arose from a single AAF-induced progenitor because the treated culture was split immediately after exposure to the carcinogen and all four mutants were cloned from separate dishes. Another possibility is that they arose as sister colonies from a spontaneous mutant clone that preexisted in the population. Although this possibility cannot be eliminated, it is unlikely on statistical grounds; the mutagenized culture yielded a mutant frequency 100-fold greater than the usual spontaneous frequency. The third possibility is that this deletion represents a hot spot for AAAF-induced deletion, the extentof the deletion being governed by some aspect of chromatin structure. If this were the case, one might have expected to see this deletion reappear in the two subsequent experiments that generated 18 more mutants. Thus, the origin of these deletion mutations remains unclear.
Both AAF and AF bind to the C-8 position ofguanine. The acetylated deoxyguanosine adduct causes a major conformational distortion in DNA structure (16, 31) . The adduct displaces the guanine ring out of the helix, and the fluorene residue is intercalated. However, the deacetylated deoxyguanosine adduct causes only small changes in DNA structure (15, 17) . Normal DNA conformation is maintained, and the fluorene residue is situated in the major groove. Using a forward mutation assay in bacteria, Koffel-Schwartz et al. (32) and Bichara and Fuchs (33) have demonstrated that the mutational specificity of the two adducts is different. They found that dG-AAF induced frameshift mutations, whereas dG-AF adducts induced mainly base substitutions. Because the acetylated and deacetylated adducts produce different conformational changes and show different mutational specificities, we analyzed the ratio of these products in the DNA of mutagenized CHO cells. We found that the ratio of dG-AAF and dG-AF adducts formed in UA21 DNA is similar to the ratio of gross-and small-lesion DHFR mutants isolated after AAAF treatment. It is not feasible to ascertain the ratio of adducts during the period in which the treated cells recover and replicate. Nonetheless, there may be a correlation between the conformational alterations induced in DNA by dG-AAF and dG-AF and the types of mutations we have identified at the DHFR locus.
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